)
Edge31 Oct 2025
Rolls-Royce: Full Thrust Ahead
From century-old crafted perfection to pandemic shock and reset, Rolls-Royce's story is shaped by heritage, turbulence, and a disciplined climb back.
ENDRA Life Sciences (NDRA) investor relations material
ENDRA Life Sciences Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary14 Aug, 2025
Executive summary
No revenue generated as of June 30, 2025; focus remains on developing and commercializing TAEUS technology for liver fat measurement and metabolic disease management.
Advanced TAEUS Liver system with improved probe design and algorithms, showing significant performance gains in initial testing against MRI-PDFF measurements.
Net loss for the quarter was $1.23M, a significant improvement from $2.23M in the same quarter last year; six-month net loss was $2.26M, down from $5.00M year-over-year.
Implemented cost reductions, including headcount decrease and streamlined operations, to strengthen financial position.
Board authorized a cryptocurrency treasury strategy in July 2025, but no cryptocurrency has been acquired yet.
Financial highlights
Operating expenses for Q2 2025 decreased 42% year-over-year to $1.3 million from $2.2 million, with reductions across R&D, sales and marketing, and G&A.
Research and development expenses for Q2 2025 were $381K, down 47% year-over-year; six-month R&D was $910K, down 48%.
Net cash used in operating activities for the six months ended June 30, 2025 was $2.41M.
Cash balance at June 30, 2025 was $1.81M, compared to $3.23M at December 31, 2024.
Net loss for Q2 2025 narrowed to $1.2M, compared to $2.2M in the prior-year period.
Outlook and guidance
Company expects continued significant expenses as it advances TAEUS technology, regulatory filings, and commercialization.
Pivotal clinical trial for TAEUS Liver expected to launch by year-end, following FDA protocol alignment.
Additional capital is required to fund operations through the next twelve months; current cash is insufficient for full commercialization.
Considering financing options, including at-the-market equity sales, but no firm commitments for additional funds.
Results from ongoing validation study to inform FDA meetings and confirm trial endpoints.
Quantify TAEUS Liver's performance improvement
What is the planned subject count for pivotal trial?
Identify potential licensing opportunities for IP
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next ENDRA Life Sciences earnings date
Q3 202514 Nov, 2025
Next ENDRA Life Sciences earnings date
Q3 202514 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
ENDRA Life Sciences Inc. is a medical technology company focused on developing advanced ultrasound technologies for clinical use. Its main product, the Thermo-Acoustic Enhanced Ultrasound (TAEUS) platform, is designed to provide imaging capabilities similar to MRI, but at a fraction of the cost and at the point of care. ENDRA’s technology is primarily aimed at improving the diagnosis and monitoring of liver disease, particularly non-alcoholic fatty liver disease (NAFLD), with potential applications in other conditions. The company is headquartered in Ann Arbor, Michigan, USA, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage